Regulation of Polyamine Metabolism by Curcumin for Cancer Prevention and Therapy
Open Access
- 18 December 2017
- journal article
- review article
- Published by MDPI AG in Medical Sciences
- Vol. 5 (4) , 38
Abstract
Curcumin (diferuloylmethane), the natural polyphenol responsible for the characteristic yellow pigment of the spice turmeric (Curcuma longa), is traditionally known for its antioxidant, anti-inflammatory, and anticarcinogenic properties. Capable of affecting the initiation, promotion, and progression of carcinogenesis through multiple mechanisms, curcumin has potential utility for both chemoprevention and chemotherapy. In human cancer cell lines, curcumin has been shown to decrease ornithine decarboxylase (ODC) activity, a rate-limiting enzyme in polyamine biosynthesis that is frequently upregulated in cancer and other rapidly proliferating tissues. Numerous studies have demonstrated that pretreatment with curcumin can abrogate carcinogen-induced ODC activity and tumor development in rodent tumorigenesis models targeting various organs. This review summarizes the results of curcumin exposure with regard to the modulation of polyamine metabolism and discusses the potential utility of this natural compound in conjunction with the exploitation of dysregulated polyamine metabolism in chemopreventive and chemotherapeutic settings.Keywords
Funding Information
- National Institutes of Health (R01-CA204345)
This publication has 95 references indexed in Scilit:
- Polyamines and cancer: implications for chemotherapy and chemopreventionExpert Reviews in Molecular Medicine, 2013
- Understanding Carcinogenesis for Fighting Oral CancerJournal of Oncology, 2011
- Polyamine catabolism and diseaseBiochemical Journal, 2009
- Risk of Cardiovascular Events in a Randomized Placebo-Controlled, Double-Blind Trial of Difluoromethylornithine plus Sulindac for the Prevention of Sporadic Colorectal AdenomasCancer Prevention Research, 2009
- Combination Chemoprevention for Colon Cancer Targeting Polyamine Synthesis and InflammationClinical Cancer Research, 2009
- Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind TrialCancer Prevention Research, 2008
- Curcumin induces apoptosis through an ornithine decarboxylase-dependent pathway in human promyelocytic leukemia HL-60 cellsLife Sciences, 2008
- Cytotoxic 3,5-bis(benzylidene)piperidin-4-ones and N-acyl analogs displaying selective toxicity for malignant cellsEuropean Journal of Medicinal Chemistry, 2008
- Polyamines and nonmelanoma skin cancerToxicology and Applied Pharmacology, 2007
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002